HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Recombinant Mycobacterium bovis bacillus Calmette-Guérin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon gamma and parasite-specific antibodies.

Abstract
The merozoite surface protein 1 (MSP1) has emerged as a leading malaria vaccine candidate at the erythrocytic stage. Recombinant bacillus Calmette-Guérin (rBCG), which expressed a COOH-terminal 15-kD fragment of MSP1 of Plasmodium yoelii (MSP1-15) as a fusion protein with a secretory protein of Mycobacterium kansasii, was constructed. Immunization of mice with this rBCG induced a higher degree of protection against blood-stage parasite infection than with recombinant MSP1-15 in the RIBI adjuvant (RIBI ImmunoChem Research, Inc., Hamilton, MT) or incomplete Freund's adjuvant systems. We studied the mechanism of protection induced by MSP1-15, and found that interferon (IFN)-gamma had a major role in protection in all adjuvant systems we examined. Mice that produced low amounts of MSP1-15 stimulated IFN-gamma and could not control parasite infection. The antibody against MSP1-15 did not play a major role in protection in this system. After parasite infection, immunoglobulin G2a antibodies, which had been produced by IFN-gamma stimulation, were induced and subsequently played an important role in eradicating parasites. Thus, both cellular and humoral immune responses were essential for protection from malaria disease. These data revealed that BCG is a powerful adjuvant to induce such a protective immune response against malaria parasites.
AuthorsS Matsumoto, H Yukitake, H Kanbara, T Yamada
JournalThe Journal of experimental medicine (J Exp Med) Vol. 188 Issue 5 Pg. 845-54 (Sep 07 1998) ISSN: 0022-1007 [Print] United States
PMID9730886 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Adjuvants, Immunologic
  • Antibodies, Protozoan
  • BCG Vaccine
  • Immune Sera
  • Malaria Vaccines
  • Merozoite Surface Protein 1
  • Peptide Fragments
  • Protein Precursors
  • Protozoan Proteins
  • Recombinant Fusion Proteins
  • Vaccines, Synthetic
  • Interleukin-4
  • Interferon-gamma
  • Nitrous Oxide
Topics
  • Adjuvants, Immunologic (administration & dosage)
  • Animals
  • Antibodies, Protozoan (biosynthesis, physiology)
  • Antibody Specificity
  • BCG Vaccine (genetics, immunology)
  • Female
  • Immune Sera (administration & dosage)
  • Interferon-gamma (biosynthesis, physiology)
  • Interleukin-4 (biosynthesis)
  • Malaria (immunology, parasitology, prevention & control)
  • Malaria Vaccines (genetics, immunology)
  • Merozoite Surface Protein 1
  • Mice
  • Mice, Inbred A
  • Mice, Inbred C3H
  • Mycobacterium bovis (genetics, immunology, metabolism)
  • Mycobacterium kansasii (genetics)
  • Nitrous Oxide (immunology)
  • Peptide Fragments (genetics, immunology)
  • Plasmodium yoelii (growth & development, immunology)
  • Protein Conformation
  • Protein Precursors (genetics, immunology, metabolism)
  • Protozoan Proteins (genetics, immunology, metabolism)
  • Rats
  • Recombinant Fusion Proteins (chemistry, immunology, metabolism)
  • Vaccines, Synthetic (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: